Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongfeng Wei

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos One|June 10, 2022
Image classification of forage grasses on Etuoke Banner using edge autoencoder networkDing Han, Minghua Tian, Caili Gong, et al.
Journal of Medicinal Chemistry|April 28, 2006
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug targetCurtis R Chong, David Z Qian, Fan Pan, et al.
Cancer Research|September 18, 2004
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584David Z Qian, Xiaofei Wang, Sushant K Kachhap, et al.
Optics Letters|May 3, 2014
Generating the orbital angular momentum of radio frequency signals using optical-true-time-delay unit based on optical spectrum processorXinlu Gao, Shanguo Huang, Yunlong Song, et al.
The Prostate|January 15, 2005
In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cellsDavid Z Qian, Mingqiang Ren, Yongfeng Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589David Z Qian, Yukihiko Kato, Shabana Shabbeer, et al.
Molecular Cancer Therapeutics|January 24, 2007
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanomaYukihiko Kato, Brenda C Salumbides, Xiao-Fei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinomaXiao-Fei Wang, David Z Qian, Mingqiang Ren, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|June 10, 2022
Image classification of forage grasses on Etuoke Banner using edge autoencoder networkDing Han, Minghua Tian, Caili Gong, et al.
Journal of Medicinal Chemistry|April 28, 2006
Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug targetCurtis R Chong, David Z Qian, Fan Pan, et al.
Cancer Research|September 18, 2004
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584David Z Qian, Xiaofei Wang, Sushant K Kachhap, et al.
Optics Letters|May 3, 2014
Generating the orbital angular momentum of radio frequency signals using optical-true-time-delay unit based on optical spectrum processorXinlu Gao, Shanguo Huang, Yunlong Song, et al.
The Prostate|January 15, 2005
In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cellsDavid Z Qian, Mingqiang Ren, Yongfeng Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589David Z Qian, Yukihiko Kato, Shabana Shabbeer, et al.
Molecular Cancer Therapeutics|January 24, 2007
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-cis-retinoic acid in human malignant melanomaYukihiko Kato, Brenda C Salumbides, Xiao-Fei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinomaXiao-Fei Wang, David Z Qian, Mingqiang Ren, et al.
Pageof 2